This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

CRISPR Discussion Group

CRISPR Discussion Group

The discovery of CRISPR–Cas systems and their development for gene-editing applications have revolutionized biomedical science. These systems are pervasive within the genomes of bacteria and archaea, where they provide adaptive immunity by targeting foreign nucleic acids for degradation. An incredibly diverse and rapidly growing set of CRISPR systems have been identified, and recent work harnessing them to target and modify specific RNA and DNA sequences has enabled a multitude of applications, such as genome editing, transcriptional modulation, forward genetic screens, lineage tracing, and more.

The CRISPR Discussion Group will advance our understanding of the cellular, molecular, and biochemical pathways of CRISPR-associated proteins, DNA repair pathways, and their applications in diverse organisms, including for human health and disease biology.

Contact

Sonya Dougal, PhD

212.298.8683

Steering Committee Members

The CRISPR Discussion Group Steering Committee, composed of multi-institutional scientists from the Academy’s network, provides thought leadership on key issues of interest to the CRISPR community, informing and shaping our program portfolio.

Britt Adamson, PhD
Britt Adamson, PhD

Princeton University

Maria Jasin, PhD
Maria Jasin, PhD

Memorial Sloan Kettering Cancer Center

Neville Sanjana, PhD
Neville Sanjana, PhD

New York University and New York Genome Center

Samuel Sternberg, PhD
Samuel Sternberg, PhD

Columbia University